FDA Grants Priority Review to Eylea HD for Macular Edema Following RVO
QUASAR Phase III study data show higher-dose aflibercept could reduce injection frequency for retinal vein occlusion patients. Bayer (Leverkusen, Germany)…
Navilas®️ Laser System: Non-contact Treatment with Enhanced Accuracy, Speed and Comfort
The innovative Navilas® Laser System (OD-OS GmbH) is revolutionizing the treatment of retinal diseases with its excellent precision, speed, comfort…
latest posts